Methotrexate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Methotrexate Injection (injection) from Assertio Specialty Pharmaceuticals, LLC with status No longer listed by FDA. The shortage was first posted on Aug 29, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Assertio Specialty Pharmaceuticals, LLC
- Package NDC
- 82497-022-04
- Dosage Form
- Injection
- Presentation
- Otrexup, Injection, 22.5 mg/.4 mL (NDC 82497-022-04)
- Initial Posting
- Aug 29, 2025